BJTRF (Beijing Tong Ren Tang Chinese Medicine Co) Ending Cash Position: $286.3 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJTRF Beijing Tong Ren Tang Chinese Medicine Co Ltd BJTRF
88 GF Score
Price $0.65
GF Value $0.99
! 3 Warning Signs
View Full Analysis

What is Beijing Tong Ren Tang Chinese Medicine Co Ending Cash Position?

Beijing Tong Ren Tang Chinese Medicine Co BJTRF 88 Ending Cash Position is $286.3 Mil as of Dec. 2025. GuruFocus rates BJTRF with a GF Score™ of 88/100 and a GF Value™ of $0.99. The stock has 3 warning signs investors should review.

Beijing Tong Ren Tang Chinese Medicine Co's Ending Cash Position for the quarter that ended in Dec. 2025 was $286.3 Mil.

Beijing Tong Ren Tang Chinese Medicine Co's quarterly Ending Cash Position declined from Dec. 2024 ($228.1 Mil) to Jun. 2025 ($227.9 Mil) but then increased from Jun. 2025 ($227.9 Mil) to Dec. 2025 ($286.3 Mil).

Beijing Tong Ren Tang Chinese Medicine Co's annual Ending Cash Position increased from Dec. 2023 ($128.0 Mil) to Dec. 2024 ($228.1 Mil) and increased from Dec. 2024 ($228.1 Mil) to Dec. 2025 ($286.3 Mil).

Beijing Tong Ren Tang Chinese Medicine Co Ending Cash Position Related Terms

Beijing Tong Ren Tang Chinese Medicine Co Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Beijing Tong Ren Tang Chinese Medicine Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beijing Tong Ren Tang Chinese Medicine Co Ending Cash Position Chart

Beijing Tong Ren Tang Chinese Medicine Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 212.89 255.73 128.02 228.10 286.33

Beijing Tong Ren Tang Chinese Medicine Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 128.02 220.42 228.10 227.93 286.33
BJTRF
88GF Score
Beijing Tong Ren Tang Chinese Medicine Co Ltd BJTRF
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Beijing Tong Ren Tang Chinese Medicine Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Beijing Tong Ren Tang Chinese Medicine Co's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=227.878+58.448
=286.3

Beijing Tong Ren Tang Chinese Medicine Co's Ending Cash Position for the quarter that ended in Dec. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=229.919+56.407
=286.3

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $286.3 Mil mean?
Beijing Tong Ren Tang Chinese Medicine Co (BJTRF) has a Ending Cash Position of $286.3 Mil as of Dec. 2025. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Beijing Tong Ren Tang Chinese Medicine Co and its competitors.
Is Beijing Tong Ren Tang Chinese Medicine Co's Ending Cash Position too high?
Beijing Tong Ren Tang Chinese Medicine Co's current Ending Cash Position is $286.3 Mil. Overall, Beijing Tong Ren Tang Chinese Medicine Co has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does Beijing Tong Ren Tang Chinese Medicine Co's Ending Cash Position compare to ZTS?
Beijing Tong Ren Tang Chinese Medicine Co's Ending Cash Position of $286.3 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Drug Manufacturers company?
A good Ending Cash Position depends on the Drug Manufacturers industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Beijing Tong Ren Tang Chinese Medicine Co and its competitors. Beijing Tong Ren Tang Chinese Medicine Co's current Ending Cash Position is $286.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Tong Ren Tang Chinese Medicine Co stock overvalued right now?
Beijing Tong Ren Tang Chinese Medicine Co (BJTRF) has a current Ending Cash Position of $286.3 Mil. The stock's GF Value™ is $0.99, compared to a current price of $0.65 — trading 34.5% below its estimated fair value. The current Ending Cash Position is $286.3 Mil. Beijing Tong Ren Tang Chinese Medicine Co's overall GF Score™ is 88/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Beijing Tong Ren Tang Chinese Medicine Co (BJTRF), the current Ending Cash Position is $286.3 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Beijing Tong Ren Tang Chinese Medicine Co (BJTRF) Overvalued in 2026?

Based on GuruFocus' analysis, Beijing Tong Ren Tang Chinese Medicine Co stock appears to be undervalued. The current stock price of $0.65 is trading 34.5% below its estimated GF Value™ of $0.99.

Key valuation signals for BJTRF:

  • Ending Cash Position: $286.3 Mil
  • GF Value™: $0.99 vs. price of $0.65 (34.5% below fair value)
  • GF Score™: 88/100 with 3 warning signs

No single metric tells the full story. See the BJTRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Beijing Tong Ren Tang Chinese Medicine Co Business Description

Other Exchanges 03613:Hong KongTQR:Germany
Address Convention Plaza, 1 Harbour Road, Room 1405-1409, Office Tower, Wanchai, Hong Kong, HKG
Beijing Tong Ren Tang Chinese Medicine Co Ltd is a pharmaceutical retailer that specializes in Chinese medicine operating in three segments; Hong Kong includes the sale of Chinese medicine products and healthcare products and the provision of Chinese medical consultation and treatments through retail and wholesale of Chinese medicine products and healthcare products; Chinese Mainland (PRC, but excluding Hong Kong, Macao, and Taiwan) includes wholesale of healthcare products in Chinese Mainland and the sole distributor of Tong Ren Tang branded products of Tong Ren Tang Technologies and Tong Ren Tang Ltd; and Overseas includes retail and wholesale of Chinese medicine products and healthcare products and provision of Chinese medical consultation and treatments.
88GF Score

Get the complete analysis for BJTRF

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.65
Price
$0.99
GF Value